(+/-) Phenylmethoxy Octahydro-Cyclopenta[B]Pyrrole-2-Carboxylate Hydrochloride

During cGMP-compliant manufacture of a non-ergoline dopamine agonist intermediate, the hydrochloride salt is charged as a pre-sieved solid through a contained transfer system into a nitrogen-purged 2000 L Hastelloy C-22 reactor. Receiving acceptance criteria under 21 CFR 211.84 mandate identity confirmation via FTIR against a qualified reference standard, residual solvent screening per Ph. Eur. 2.4.24, and a water content determination of ≤0.15% by ISO 760 coulometric Karl Fischer titration. The molar addition ratio is fixed at 1.02–1.05 equivalents relative to the 3-chloro-4-fluorophenyl ketone intermediate, with the salt form deliberately selected to suppress side-reactions that occur when the free base generates uncontrolled exotherms during anhydride activation. Anhydrous tetrahydrofuran (water <50 ppm monitored by near-infrared inline probe) is added to achieve a 0.45 M substrate concentration. The mixture is then cooled at a controlled ramp of −0.5 °C/min to −18 °C while a stoichiometric quantity of lithium hexamethyldisilazide (1.0 M in THF) is dosed below the liquid surface at a rate maintaining internal temperature ≤−12 °C. After 45 minutes of aging, the diastereoselective alkylation is complete by TLC (hexane:ethyl acetate 3:1, R_f shift 0.30 to 0.55). Quenching with 10% w/w aqueous ammonium chloride is conducted in a buffer tank to prevent localized pH excursions. The crude ethyl acetate extract is washed, concentrated on a wiped-film evaporator (jacket 35 °C, vacuum 20 mbar), and the residue is subjected to a two-step crystallization. Initial polymorph seeding in isopropanol:n-heptane (1:4 v/v) at 50 °C yields a first-crop purity of 98.8%; a subsequent reslurry in methyl tert-butyl ether at 40 °C for 4 hours upgrades to 99.85% with a single impurity (the des-fluoro analogue) below 0.05%. The isolated product serves as the penultimate intermediate for a D2/D3 receptor partial agonist currently registered under a Type II DMF with the US FDA. Production-scale bottlenecks encountered at the reslurry filtration stage—specifically, a tendency for needle-like habit to blind a 5 μm sintered stainless-steel filter plate at batch sizes above 80 kg—have been addressed by installing a pressurized agitated nutsche filter/dryer and applying a constant 0.3 bar nitrogen overpressure during deliquoring.

Can reversing the amide formation sequence suppress epimerization in constrained peptidomimetics?

The hydrochloride is employed pre-dissolved in anhydrous N,N-dimethylformamide containing 0.5% v/v 2,4,6-collidine to buffer residual acidity. Activation is performed by adding 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide (EDC·HCl, 1.10 eq) and 1-hydroxy-7-azabenzotriazole (HOAt, 1.15 eq) at 0–5 °C for 20 minutes before coupling to a deprotected resin-bound tetrapeptide on a PEG-grafted polystyrene support. The addition ratio relative to free amine sites on the resin is maintained at 2.5 equivalents to overcome diffusion limitations within the swollen polymer matrix; diisopropylethylamine is metered in to keep the apparent pH of the slurry at 8.0–8.3 (monitored by a micro-pH probe inserted at the reactor drain). The vessel, a jacketed solid-phase synthesis reactor with a 15 μm polyethylene frit, is oscillated at 25 rpm for 6 hours at 22 °C. Exhaustive washing sequences—3× DMF, 2× DCM, 1× methanol—remove unreacted monomer before a chloranil test confirms absence of free secondary amine. Cleavage from the resin is effected with a cocktail of trifluoroacetic acid:triisopropylsilane:water (95:2.5:2.5 v/v/v) over 2.5 hours, followed by precipitation in cold diethyl ether. The crude linear peptide mimetic is purified by reversed-phase preparative HPLC (C18, 10 μm, 100 Å; mobile phase acetonitrile/water + 0.1% TFA) and lyophilized. The resulting conformationally restricted bicyclic peptidomimetic, which carries the octahydro-cyclopenta[b]pyrrole scaffold as a type VI β-turn mimic, is produced in milligram-to-gram quantities under ISO 13485 quality management for a discovery-stage integrin α_vβ₃ antagonist program. Epimerization at the α-carbon is suppressed to <1.5% D-isomer by ¹H NMR integration of the Hα doublet, validated against a spiked standard. The process is executed on a 20-channel automated peptide synthesizer (MultiPep CF) calibrated to deliver coupling efficiencies above 99.2% per step as measured by Fmoc release UV monitoring at 301 nm.

Chiral derivatization agent for enantiomeric excess determination in exploratory lead-optimization libraries

A single isomeric form of the hydrochloride is reacted in parallel with crude chiral amine fractions harvested from split-pool solid-phase synthesis. Aliquots of amine (approximately 5 μmol) in a 96-well polypropylene plate are treated with the derivatizing agent at 1.3 molar equivalents in acetonitrile containing 0.1 M N-methylmorpholine. The plate is heat-sealed and shaken at 25 °C for 90 minutes. Excess reagent is scavenged with aminomethyl polystyrene resin (3.0 eq, 1.8 mmol/g loading) for 30 minutes to prevent column deterioration. The derivatized samples are analyzed by reversed-phase ultra-performance liquid chromatography on a sub-2 μm C18 column (2.1 × 50 mm) with a linear gradient of 10–90% methanol in ammonium formate buffer (pH 3.5) over 4.5 minutes. Separation of the resulting diastereomeric amides yields a resolution factor Rs of 4.2 between the (S,S) and (R,S) pairs, determined in a system suitability test per Ph. Eur. 2.2.46. This methodology, qualified under ICH Q2(R1) for linearity, precision, and LOQ, enables an enantiomeric excess limit of quantification of 99.5% ee. The barrier to implementation on the manufacturing floor involves the hygroscopic nature of the hydrochloride: in laboratories where relative humidity exceeds 60%, pre-drying of the well plate at 40 °C under vacuum for 20 minutes is mandatory, otherwise capillary condensation in the needle tips of the liquid handler introduces weigh errors exceeding 2.5%.

Moisture-sensitive Negishi coupling steps in agricultural lead optimization programs employ the free base generated in situ from the hydrochloride by treatment with a non-nucleophilic amidine base. The transformation is carried out in a glovebox maintained at <1 ppm O₂ and <1 ppm H₂O, where the hydrochloride (addition ratio 1.0 eq) is suspended in anhydrous 1,4-dioxane and deprotonated with 1.05 eq of 1,8-diazabicyclo[5.4.0]undec-7-ene at 23 °C for 15 minutes. Activated zinc dust (1.7 eq, –325 mesh) is added, and the resulting organozinc reagent is cannulated into a flask containing the heteroaryl bromide electrophile and Pd-PEPPSI-IPent catalyst (3 mol%). Cross-coupling proceeds at 55 °C over 12 hours to yield the protected biaryl pyrrole scaffold. After acidic work-up and flash chromatography (silica gel 60, ethyl acetate/cyclohexane 15:85 to 40:60), the intermediate is further elaborated into a phenylpyrazole GABA-gated chloride channel antagonist intended for foliar application on row crops. The entire process falls under Regulation (EC) No 1107/2009 for active substance approval in Europe, with a five-batch analysis dossier submitted demonstrating chemical equivalence per FAO Specification Manual, November 2021 revision. A distinct scale-up risk emerges when the batch size exceeds 500 g: the exothermic zinc insertion into the carbon-chlorine bond of the HCl precursor can initiate runaway if the heat transfer from the stirred reactor lags behind the dosing rate, requiring a maximum jacket temperature offset of +3 °C above the set point.

When sublimation temperature and glass transition conflict in wet-processed OLED interlayers

The hydrochloride is purified by gradient sublimation in a three-zone tube furnace (zone 1: 140 °C; zone 2: 210 °C; zone 3: 60 °C, base pressure <2×10⁻⁵ mbar), a step necessary to reduce alkali metal ion content below 10 ppb for device stability. The purified material is co-deposited with a commercial 4,4′-bis(N-carbazolyl)-1,1′-biphenyl host in a thermal evaporator equipped with six independent Knudsen cells. The doping rate is controlled by separate quartz crystal microbalances to achieve a uniform 6.5 wt% inclusion in the hole-transport layer. During deposition, the substrate holder is rotated at 10 rpm to ensure thickness uniformity of ±1.5% across a 200 × 200 mm glass panel. The inclusion of this pyrrole-fused heterocycle elevates the glass transition temperature of the doped film from 75 °C to 112 °C as measured by modulated differential scanning calorimetry per ASTM E1356-23, thereby inhibiting recrystallization-induced dark spots during a 85 °C/85% RH shelf-life test over 1000 hours. Compliance is maintained with IEC 62368-1 clause 6.2 for optical radiation safety, as the emission spectrum of the phosphorescent test devices (external quantum efficiency 22.3% at 1000 cd/m²) falls within the exempt risk group. The major operational limitation concerns the narrow processing window: at doping concentrations above 8.0 wt%, aggregation-induced quenching reduces the charge carrier mobility by approximately two orders of magnitude, from 1.2×10⁻⁴ cm²/V·s to 8.7×10⁻⁷ cm²/V·s, as extracted from space-charge-limited current measurements on single-carrier devices.

Vapour-phase corrosion inhibitor for intergranular attack suppression in ferrous packaging

A masterbatch containing 0.8 wt% of the hydrochloride is prepared in a diocryl adipate carrier by triple-pass through a three-roll mill with a 15 μm gap setting. This concentrate is then let down to a light mineral oil base to achieve a final loading of 0.15 wt%. The formulated fluid is applied by electrostatic spray to cold-rolled steel coupons (SAE 1008) and placed in a humidity cabinet programmed to 40 °C/95% RH for 500 hours per ASTM B117-19. Inhibitor efficiency, calculated from mass loss relative to an unprotected control, exceeds 92%. Compliance documentation references RoHS Directive 2011/65/EU Annex II for the absence of hexavalent chromium and the 4 + 1 phthalates. The terminal product category encompasses VCI (volatile corrosion inhibitor) polyethylene films and emitter cups used to protect transmission gears during intercontinental shipment.